• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Canada Goose Holdings Inc. Subordinate Voting Shares

    2/14/24 3:55:44 PM ET
    $GOOS
    Apparel
    Consumer Discretionary
    Get the next $GOOS alert in real time by email
    SC 13G 1 goos_21424.htm PATIENT CAPITAL MANAGEMENT, LLC goos_21424.htm
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    CANADA GOOSE HOLDINGS INC
    (Name of Issuer)
    Subordinated Shares
    (Title of Class of Securities)
    135086106
    (CUSIP Number)
    December 29, 2023
    (Date of Event which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    [X] Rule 13d-1(b)
    [   ] Rule 13d-1(c)
    [   ] Rule 13d-1(d)
    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see Instructions).
    CUSIP No.: 135086106
           
    1
    NAME OF REPORTING PERSON
    Patient Capital Management, LLC
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
    84-4277115
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) [   ]
    (b) [   ]
    3 SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5
    SOLE VOTING POWER
    3,842,824
    6
    SHARED VOTING POWER
    7
    SOLE DISPOSITIVE POWER
    3,842,824
    8
    SHARED DISPOSITIVE POWER
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    3,842,824
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    [   ]
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    8.14%
    12
    TYPE OF REPORTING PERSON
    IA
    CUSIP No.: 135086106
           
    1
    NAME OF REPORTING PERSON
    Patient Opportunity Trust, a series of Advisor Managed Portfolios
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
    52-2203385
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) [   ]
    (b) [   ]
    3 SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5
    SOLE VOTING POWER
    6
    SHARED VOTING POWER
    3,000,000
    7
    SOLE DISPOSITIVE POWER
    8
    SHARED DISPOSITIVE POWER
    3,000,000
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    3,000,000 (this amount is also included in the aggregate amount reported by Patient Capital Management, LLC)
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    [   ]
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    6.35%
    12
    TYPE OF REPORTING PERSON
    IV
    CUSIP No.: 135086106
    ITEM 1(a). NAME OF ISSUER:
    CANADA GOOSE HOLDINGS INC
    ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
    250 Bowie Ave

    Toronto, Ontario, Canada
    ITEM 2(a). NAME OF PERSON FILING:
    Patient Capital Management, LLC
    Patient Opportunity Trust, a series of Advisor Managed Portfolios
    ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
    One South Street, Suite 2550
    Baltimore, MD 21202
    ITEM 2(c). CITIZENSHIP:
    Delaware
    Delaware
    ITEM 2(d). TITLE OF CLASS OF SECURITIES:
    Subordinated Shares
    ITEM 2(e). CUSIP NUMBER:
    135086106
    ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A:
    (a)
    [ ]
    Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c);
    (b)
    [ ]
    Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)
    [ ]
    Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)
    [X]
    Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
    (e)
    [X]
    An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
    (f)
    [ ]
    An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
    (g)
    [ ]
    A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
    (h)
    [ ]
    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)
    [ ]
    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)
    [ ]
    A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);
    (k)
    [ ]
    Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution:
    ITEM 4. OWNERSHIP
    (a) Amount beneficially owned:
    1) Patient Capital Management, LLC is deemed to be the beneficial owner of 3,842,824 shares of common stock.

    2) Patient Opportunity Trust is deemed to be beneficial owner of 3,000,000 shares of common stock.
    (b) Percent of class:
    1) Patient Capital Management, LLC - 8.14%

    2) Patient Opportunity Trust - 6.35%
    (c) Number of shares as to which the person has:
    (i) sole power to vote or to direct the vote:
    Patient Capital Management, LLC : 3,842,824

    Patient Opportunity Trust, a series of Advisor Managed Portfolios :
    (ii) shared power to vote or to direct the vote:
    Patient Capital Management, LLC :

    Patient Opportunity Trust, a series of Advisor Managed Portfolios : 3,000,000
    (iii) sole power to dispose or direct the disposition of:
    Patient Capital Management, LLC : 3,842,824

    Patient Opportunity Trust, a series of Advisor Managed Portfolios :
    (iv) shared power to dispose or to direct the disposition of:
    Patient Capital Management, LLC :

    Patient Opportunity Trust, a series of Advisor Managed Portfolios : 3,000,000
    ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].
    ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
    Various accounts managed by Patient Capital Management, LLC have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities. The interest of one account, Patient Opportunity Trust, a series of Advisor Managed Portfolios, an investment company registered under the Investment Company Act of 1940 and managed by Patient Capital Management, LLC was deemed to be the beneficial owner of 3,000,000 shares or 6.35% of the total shares outstanding as of December 29, 2023.
    ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
    See Exhibit A
    ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
    N/A
    ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
    N/A
    ITEM 10. CERTIFICATION:
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
    CUSIP No.: 135086106
    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
    February 14 2024
    Patient Capital Management, LLC
    By:
    /s/ Milton Dodge
    Name:
    Milton Dodge
    Title:
    Chief Compliance Officer
    February 14 2024
    By:
    /s/ Russell B. Simon
    Name:
    Russell B. Simon
    Title:
    CFO/Treasurer
    Attention — Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).
    CUSIP No.: 135086106
    Exhibit A

    Joint Filing Agreement

    Patient Capital Management, LLC (an investment adviser registered under the Investment Advisers Act of 1940) and Patient Opportunity Trust, hereby agree to file jointly the statement on Schedule 13G to which this Agreement is attached, and any amendments thereto which may be deemed necessary, pursuant to Regulation 13D-G under the Securities Exchange Act of 1934.

    It is understood and agreed that each of the parties hereto is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein, but such party is not responsible for the completeness or accuracy of information concerning the other party unless such party knows or has reason to believe that such information is inaccurate.

    Patient Capital Management, LLC
    Date: February 14, 2024
    Signature: /s/ Milton Dodge
    Name & Title: Milton Dodge, Chief Compliance Officer of Patient Capital Management, LLC

    Patient Opportunity Trust, a series of Advisor Managed Portfolios
    Date: February 14, 2024
    Signature: /s/ Russell B. Simon
    Name & Title: Russell B. Simon, CFO/Treasurer of Advisor Managed Portfolios
    Get the next $GOOS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GOOS

    DatePrice TargetRatingAnalyst
    2/6/2026$10.00Equal Weight → Underweight
    Barclays
    9/8/2025$18.00Hold → Buy
    TD Cowen
    8/26/2025Neutral → Outperform
    Robert W. Baird
    8/1/2025Equal Weight → Overweight
    Wells Fargo
    7/11/2025$14.00Underweight → Equal Weight
    Barclays
    4/30/2025Underweight → Equal Weight
    Wells Fargo
    3/31/2025$10.00 → $8.00Equal Weight → Underweight
    Barclays
    10/21/2024$11.50 → $9.00Neutral → Sell
    Goldman
    More analyst ratings

    $GOOS
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Canada Goose Holdings Inc. Subordinate Voting Shares

    SCHEDULE 13G/A - Canada Goose Holdings Inc. (0001690511) (Subject)

    2/17/26 4:30:03 PM ET
    $GOOS
    Apparel
    Consumer Discretionary

    SEC Form 6-K filed by Canada Goose Holdings Inc. Subordinate Voting Shares

    6-K - Canada Goose Holdings Inc. (0001690511) (Filer)

    2/5/26 7:37:45 AM ET
    $GOOS
    Apparel
    Consumer Discretionary

    SEC Form SCHEDULE 13G filed by Canada Goose Holdings Inc. Subordinate Voting Shares

    SCHEDULE 13G - Canada Goose Holdings Inc. (0001690511) (Subject)

    1/16/26 4:04:41 PM ET
    $GOOS
    Apparel
    Consumer Discretionary

    $GOOS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canada Goose downgraded by Barclays with a new price target

    Barclays downgraded Canada Goose from Equal Weight to Underweight and set a new price target of $10.00

    2/6/26 8:06:40 AM ET
    $GOOS
    Apparel
    Consumer Discretionary

    Canada Goose upgraded by TD Cowen with a new price target

    TD Cowen upgraded Canada Goose from Hold to Buy and set a new price target of $18.00

    9/8/25 8:37:17 AM ET
    $GOOS
    Apparel
    Consumer Discretionary

    Canada Goose upgraded by Robert W. Baird

    Robert W. Baird upgraded Canada Goose from Neutral to Outperform

    8/26/25 8:08:44 AM ET
    $GOOS
    Apparel
    Consumer Discretionary

    $GOOS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Canada Goose Appoints Patrick Bourke as President, North America

    Canada Goose Holdings Inc. (NYSE:GOOS, TSX:GOOS) today announced the appointment of Patrick Bourke as President, North America, effective February 5, 2026. Bourke will oversee the brand's North American business with responsibility for driving brand momentum, strengthening retail and wholesale execution, and deepening consumer connections across the region. He will partner closely with the global leadership team to advance the company's operating imperatives, with a focus on brand heat, strategic channel expansion, and operating with pace and accountability. "Patrick is an action‑oriented, high‑energy leader with a strong track record of delivering results," said Dani Reiss, Chairman & CE

    2/5/26 6:50:00 AM ET
    $GOOS
    Apparel
    Consumer Discretionary

    Canada Goose Reports Third Quarter Fiscal 2026 Results

    Third quarter revenue grew 14% year-over-year led by strong performance in US and Mainland China 4 consecutive quarters of positive DTC comparable sales growth1 Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) announced today financial results for the third quarter of fiscal 2026 ended December 28, 2025. All amounts are in Canadian dollars unless otherwise indicated. "Our third‑quarter results underscore the strength of our global brand and top‑line engine, with broad‑based revenue growth and continued momentum across key regions and channels," said Dani Reiss, Chairman and CEO of Canada Goose. "Our peak selling period reflected sharper execution — higher quality traffic driven by integra

    2/5/26 6:45:00 AM ET
    $GOOS
    Apparel
    Consumer Discretionary

    Canada Goose to Announce Third Quarter Fiscal Year 2026 Financial Results on February 5, 2026

    Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) plans to announce results for the third quarter of fiscal year 2026, which ended December 28, 2025, before markets open on Thursday, February 5, 2026. The Company will host a conference call and webcast to discuss third quarter fiscal 2026 results at 8:30am ET on Thursday, February 5, 2026. A live webcast of the conference call will be available on the company's website at http://investor.canadagoose.com. The conference call can be accessed by using the following link: Canada Goose Q3 2026 Earnings Call. After registering, an email including the conference call link will be sent to join the live call. An archived replay of the webcast will be

    1/15/26 7:00:00 AM ET
    $GOOS
    Apparel
    Consumer Discretionary

    $GOOS
    Leadership Updates

    Live Leadership Updates

    View All

    Canada Goose Appoints Patrick Bourke as President, North America

    Canada Goose Holdings Inc. (NYSE:GOOS, TSX:GOOS) today announced the appointment of Patrick Bourke as President, North America, effective February 5, 2026. Bourke will oversee the brand's North American business with responsibility for driving brand momentum, strengthening retail and wholesale execution, and deepening consumer connections across the region. He will partner closely with the global leadership team to advance the company's operating imperatives, with a focus on brand heat, strategic channel expansion, and operating with pace and accountability. "Patrick is an action‑oriented, high‑energy leader with a strong track record of delivering results," said Dani Reiss, Chairman & CE

    2/5/26 6:50:00 AM ET
    $GOOS
    Apparel
    Consumer Discretionary

    Canada Goose Strengthens Executive Team with SVP of Merchandising, Judit Bankus

    Luxury leader to drive long-term merchandising strategy Today, Canada Goose announced Judit Bankus as Senior Vice President of Merchandising. Judit will play a key role in shaping the brand's product roadmap through a lens of sustainability and innovation, to support the company's long-term growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250128073823/en/Judit Bankus (Photo: Business Wire) Reporting to Carrie Baker, President, Brand & Commercial, Judit will oversee the development and execution of global merchandising and pricing strategies, guiding the expansion across both existing and emerging product categories. She

    1/28/25 7:00:00 AM ET
    $GOOS
    Apparel
    Consumer Discretionary

    Canada Goose Welcomes Alfredo Cunanan Mendoza Tan as Chief Digital & Information Officer

    Alfredo will oversee all consumer-facing digital platforms, as well as IT, Digital Media & Marketing and Consumer Insights Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) announced today Alfredo C. M. Tan as our new Chief Digital & Information Officer, effective August 7, 2024. Alfredo takes over for Matt Blonder who will be departing Canada Goose. As Chief Digital & Information Officer, Alfredo C. M. Tan will be responsible for the strategy, implementation and adoption of all consumer-facing digital platforms. He will drive the brand's digital capabilities and lead the teams responsible for developing the company's digital roadmap across digital sales channels, as well as the company's IT

    7/12/24 7:00:00 AM ET
    $GOOS
    Apparel
    Consumer Discretionary

    $GOOS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Canada Goose Holdings Inc. Subordinate Voting Shares

    SC 13G/A - Canada Goose Holdings Inc. (0001690511) (Subject)

    11/14/24 12:31:28 PM ET
    $GOOS
    Apparel
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Canada Goose Holdings Inc. Subordinate Voting Shares

    SC 13G/A - Canada Goose Holdings Inc. (0001690511) (Subject)

    11/12/24 11:54:03 AM ET
    $GOOS
    Apparel
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Canada Goose Holdings Inc. Subordinate Voting Shares

    SC 13G/A - Canada Goose Holdings Inc. (0001690511) (Subject)

    11/6/24 5:31:25 PM ET
    $GOOS
    Apparel
    Consumer Discretionary

    $GOOS
    Financials

    Live finance-specific insights

    View All

    Canada Goose Reports Third Quarter Fiscal 2026 Results

    Third quarter revenue grew 14% year-over-year led by strong performance in US and Mainland China 4 consecutive quarters of positive DTC comparable sales growth1 Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) announced today financial results for the third quarter of fiscal 2026 ended December 28, 2025. All amounts are in Canadian dollars unless otherwise indicated. "Our third‑quarter results underscore the strength of our global brand and top‑line engine, with broad‑based revenue growth and continued momentum across key regions and channels," said Dani Reiss, Chairman and CEO of Canada Goose. "Our peak selling period reflected sharper execution — higher quality traffic driven by integra

    2/5/26 6:45:00 AM ET
    $GOOS
    Apparel
    Consumer Discretionary

    Canada Goose to Announce Third Quarter Fiscal Year 2026 Financial Results on February 5, 2026

    Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) plans to announce results for the third quarter of fiscal year 2026, which ended December 28, 2025, before markets open on Thursday, February 5, 2026. The Company will host a conference call and webcast to discuss third quarter fiscal 2026 results at 8:30am ET on Thursday, February 5, 2026. A live webcast of the conference call will be available on the company's website at http://investor.canadagoose.com. The conference call can be accessed by using the following link: Canada Goose Q3 2026 Earnings Call. After registering, an email including the conference call link will be sent to join the live call. An archived replay of the webcast will be

    1/15/26 7:00:00 AM ET
    $GOOS
    Apparel
    Consumer Discretionary

    Canada Goose Reports Second Quarter Fiscal 2026 Results

    Momentum continues with DTC comparable sales growth1 of 10%, 3 consecutive quarters of positive growth Canada Goose Holdings Inc. ((NYSE, TSX:GOOS) announced today financial results for the second quarter of fiscal 2026 ended September 28, 2025. All amounts are in Canadian dollars unless otherwise indicated. "Our second quarter results reflect strong DTC performance and positive comparable sales growth - clear proof our strategy is working," said Dani Reiss, Chairman and CEO of Canada Goose. "We're exactly where we planned to be, investing with intention, elevating our product offering, brand and consumer experiences, and entering peak season with confidence." Second Quarter Fiscal 2026

    11/6/25 6:45:00 AM ET
    $GOOS
    Apparel
    Consumer Discretionary